| Product Code: ETC9512614 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Gene Therapy Products Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Gene Therapy Products Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Gene Therapy Products Market - Industry Life Cycle |
3.4 Suriname Gene Therapy Products Market - Porter's Five Forces |
3.5 Suriname Gene Therapy Products Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Suriname Gene Therapy Products Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Suriname Gene Therapy Products Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Gene Therapy Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders in Suriname |
4.2.2 Technological advancements in gene therapy products |
4.2.3 Growing investments in healthcare infrastructure in Suriname |
4.3 Market Restraints |
4.3.1 High cost associated with gene therapy products |
4.3.2 Limited awareness and understanding of gene therapy in Suriname |
4.3.3 Regulatory challenges and approval processes for gene therapy products |
5 Suriname Gene Therapy Products Market Trends |
6 Suriname Gene Therapy Products Market, By Types |
6.1 Suriname Gene Therapy Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Suriname Gene Therapy Products Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Suriname Gene Therapy Products Market Revenues & Volume, By Yescarta, 2021- 2031F |
6.1.4 Suriname Gene Therapy Products Market Revenues & Volume, By Kymriah, 2021- 2031F |
6.1.5 Suriname Gene Therapy Products Market Revenues & Volume, By Luxturna, 2021- 2031F |
6.1.6 Suriname Gene Therapy Products Market Revenues & Volume, By Strimvelis, 2021- 2031F |
6.1.7 Suriname Gene Therapy Products Market Revenues & Volume, By Gendicine, 2021- 2031F |
6.2 Suriname Gene Therapy Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Gene Therapy Products Market Revenues & Volume, By Oncological Disorders, 2021- 2031F |
6.2.3 Suriname Gene Therapy Products Market Revenues & Volume, By Rare Diseases, 2021- 2031F |
6.2.4 Suriname Gene Therapy Products Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.5 Suriname Gene Therapy Products Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.6 Suriname Gene Therapy Products Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.7 Suriname Gene Therapy Products Market Revenues & Volume, By Other Diseases, 2021- 2031F |
6.3 Suriname Gene Therapy Products Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Suriname Gene Therapy Products Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Suriname Gene Therapy Products Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.4 Suriname Gene Therapy Products Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.5 Suriname Gene Therapy Products Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Gene Therapy Products Market Import-Export Trade Statistics |
7.1 Suriname Gene Therapy Products Market Export to Major Countries |
7.2 Suriname Gene Therapy Products Market Imports from Major Countries |
8 Suriname Gene Therapy Products Market Key Performance Indicators |
8.1 Number of clinical trials for gene therapy products conducted in Suriname |
8.2 Adoption rate of gene therapy products by healthcare providers in Suriname |
8.3 Number of research collaborations between local institutions and global gene therapy companies in Suriname |
9 Suriname Gene Therapy Products Market - Opportunity Assessment |
9.1 Suriname Gene Therapy Products Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Suriname Gene Therapy Products Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Suriname Gene Therapy Products Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Gene Therapy Products Market - Competitive Landscape |
10.1 Suriname Gene Therapy Products Market Revenue Share, By Companies, 2024 |
10.2 Suriname Gene Therapy Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here